294 related articles for article (PubMed ID: 23636864)
1. Anti-inflammatory strategies for plaque stabilization after acute coronary syndromes.
Baruch A; van Bruggen N; Kim JB; Lehrer-Graiwer JE
Curr Atheroscler Rep; 2013 Jun; 15(6):327. PubMed ID: 23636864
[TBL] [Abstract][Full Text] [Related]
2. Inflammation and its resolution as determinants of acute coronary syndromes.
Libby P; Tabas I; Fredman G; Fisher EA
Circ Res; 2014 Jun; 114(12):1867-79. PubMed ID: 24902971
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-17 and acute coronary syndrome.
Su SA; Ma H; Shen L; Xiang MX; Wang JA
J Zhejiang Univ Sci B; 2013 Aug; 14(8):664-9. PubMed ID: 23897784
[TBL] [Abstract][Full Text] [Related]
4. The Beneficial Therapy with Colchicine for Atherosclerosis via Anti-inflammation and Decrease in Hypertriglyceridemia.
Spartalis M; Spartalis E; Tzatzaki E; Tsilimigras DI; Moris D; Kontogiannis C; Kaminiotis VV; Paschou SA; Chatzidou S; Siasos G; Voudris V; Iliopoulos DC
Cardiovasc Hematol Agents Med Chem; 2018; 16(2):74-80. PubMed ID: 30526472
[TBL] [Abstract][Full Text] [Related]
5. Do we know enough about the immune pathogenesis of acute coronary syndromes to improve clinical practice?
Matusik P; Guzik B; Weber C; Guzik TJ
Thromb Haemost; 2012 Sep; 108(3):443-56. PubMed ID: 22872109
[TBL] [Abstract][Full Text] [Related]
6. Acute Coronary Syndromes: The Way Forward From Mechanisms to Precision Treatment.
Crea F; Libby P
Circulation; 2017 Sep; 136(12):1155-1166. PubMed ID: 28923905
[TBL] [Abstract][Full Text] [Related]
7. The Role of Colchicine in Acute Coronary Syndromes.
Vaidya K; Martínez G; Patel S
Clin Ther; 2019 Jan; 41(1):11-20. PubMed ID: 30185392
[TBL] [Abstract][Full Text] [Related]
8. Role of vascular inflammation in coronary artery disease: potential of anti-inflammatory drugs in the prevention of atherothrombosis. Inflammation and anti-inflammatory drugs in coronary artery disease.
Moreira DM; da Silva RL; Vieira JL; Fattah T; Lueneberg ME; Gottschall CA
Am J Cardiovasc Drugs; 2015 Feb; 15(1):1-11. PubMed ID: 25369900
[TBL] [Abstract][Full Text] [Related]
9. Targeting the unstable plaque in acute coronary syndromes.
Thompson PL; Nidorf SM; Eikelboom J
Clin Ther; 2013 Aug; 35(8):1099-107. PubMed ID: 23973042
[TBL] [Abstract][Full Text] [Related]
10. Platelets, inflammation and anti-inflammatory effects of antiplatelet drugs in ACS and CAD.
Müller KA; Chatterjee M; Rath D; Geisler T
Thromb Haemost; 2015 Aug; 114(3):498-518. PubMed ID: 26224127
[TBL] [Abstract][Full Text] [Related]
11. Pro-inflammatory Cytokines in Acute Coronary Syndromes.
Mourouzis K; Oikonomou E; Siasos G; Tsalamadris S; Vogiatzi G; Antonopoulos A; Fountoulakis P; Goliopoulou A; Papaioannou S; Tousoulis D
Curr Pharm Des; 2020; 26(36):4624-4647. PubMed ID: 32282296
[TBL] [Abstract][Full Text] [Related]
12. Reverse vessel remodeling but not coronary plaque regression could predict future cardiovascular events in ACS patients with intensive statin therapy--the extended JAPAN-ACS study.
Miyauchi K; Daida H; Morimoto T; Hiro T; Kimura T; Nakagawa Y; Yamagishi M; Ozaki Y; Kadota K; Kimura K; Hirayama A; Kimura K; Hasegawa Y; Uchiyama S; Matsuzaki M;
Circ J; 2012; 76(4):825-32. PubMed ID: 22451449
[TBL] [Abstract][Full Text] [Related]
13. Colchicine Therapy and Plaque Stabilization in Patients With Acute Coronary Syndrome: A CT Coronary Angiography Study.
Vaidya K; Arnott C; Martínez GJ; Ng B; McCormack S; Sullivan DR; Celermajer DS; Patel S
JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 2):305-316. PubMed ID: 29055633
[TBL] [Abstract][Full Text] [Related]
14. Colchicine in Stable Coronary Artery Disease.
Fiolet ATL; Nidorf SM; Mosterd A; Cornel JH
Clin Ther; 2019 Jan; 41(1):30-40. PubMed ID: 30396516
[TBL] [Abstract][Full Text] [Related]
15. [The role of inflammation in the pathophysiology of acute coronary syndromes].
Alber HF; Suessenbacher A; Weidinger F
Wien Klin Wochenschr; 2005 Jul; 117(13-14):445-55. PubMed ID: 16091870
[TBL] [Abstract][Full Text] [Related]
16. Platelets, inflammation and anti-inflammatory drugs in ACS and CAD.
Schrör K; Huber K
Thromb Haemost; 2015 Aug; 114(3):446-8. PubMed ID: 26288949
[No Abstract] [Full Text] [Related]
17. Impact of inflammation-mediated response on pan-coronary plaque vulnerability, myocardial viability and ventricular remodeling in the postinfarction period - the VIABILITY study: Protocol for a non-randomized prospective clinical study.
Morariu M; Hodas R; Benedek T; Benedek I; Opincariu D; Mester A; Chitu M; Kovacs I; Rezus C; Pasaroiu D; Mitra N; Szilágyi SM; Georgescu D; Rezus E
Medicine (Baltimore); 2019 Apr; 98(17):e15194. PubMed ID: 31027064
[TBL] [Abstract][Full Text] [Related]
18. Advances in mechanisms, imaging and management of the unstable plaque.
Niccoli G; Liuzzo G; Montone RA; Crea F
Atherosclerosis; 2014 Apr; 233(2):467-477. PubMed ID: 24530781
[TBL] [Abstract][Full Text] [Related]
19. Multiple plaque rupture and C-reactive protein in acute myocardial infarction.
Tanaka A; Shimada K; Sano T; Namba M; Sakamoto T; Nishida Y; Kawarabayashi T; Fukuda D; Yoshikawa J
J Am Coll Cardiol; 2005 May; 45(10):1594-9. PubMed ID: 15893172
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil-derived microparticles are released into the coronary circulation following percutaneous coronary intervention in acute coronary syndrome patients.
Martínez GJ; Barraclough JY; Nakhla S; Kienzle V; Robertson S; Mallat Z; Celermajer DS; Patel S
Biosci Rep; 2017 Feb; 37(1):. PubMed ID: 27913753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
